Suppr超能文献

载利福平 PLGA 微球的制备通过预混膜匀浆法用于肺部气溶胶给药。

Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.

机构信息

INSERM, ERI-23, 40 avenue du Recteur Pineau, 86000 Poitiers, France.

出版信息

Int J Pharm. 2009 Dec 1;382(1-2):61-6. doi: 10.1016/j.ijpharm.2009.08.008. Epub 2009 Aug 12.

Abstract

The water-in-oil solvent evaporation method with premix membrane homogenization was investigated to improve productivity of the preparation of narrowly size-distributed poly(lactide-co-glycolide) (PLGA) microspheres for rifampicin lung delivery as dry aerosols. Using ethyl acetate as organic solvent, a coarse oil-in-water emulsion (or premix) was prepared under magnetic stirring and homogenized by extrusion through a Shirasu porous glass (SPG) membrane (5.9 microm porosity). Microspheres were obtained after dilution and solvent evaporation. Formulation parameters investigated were: PLGA concentration, transmembrane pressure and oil:water volume ratio. The optimal formulation parameters were then applied to prepare rifampicin-loaded microspheres. Loaded microspheres were 1.72+/-0.16 microm in diameter with a span of 0.86+/-0.04 and a rifampicin content of 52+/-6 microg/mg microspheres. Release studies in phosphate-buffered saline showed a linear release profile with 40% rifampicin release over 4.5 days. The MMAD of 2.63 microm of freeze-dried microspheres should be suitable for aerosol administration and delivery into the rat lungs by intratracheal insufflation.

摘要

水包油溶剂蒸发法与预混膜匀化法联合应用以提高载利福平聚乳酸-聚乙醇酸共聚物(PLGA)微球的制备产量,使其可作为干粉气溶胶用于肺部给药。采用乙酸乙酯作为有机溶剂,在磁力搅拌下制备粗的油包水乳液(或预混物),然后通过 Shirasu 多孔玻璃(SPG)膜(5.9 微米孔径)挤出进行匀化。稀释并蒸发溶剂后即可得到微球。考察的制剂参数有:PLGA 浓度、跨膜压力和油:水体积比。然后将最优制剂参数应用于载利福平微球的制备。载药微球的平均粒径为 1.72+/-0.16 微米,多分散指数为 0.86+/-0.04,载药微球中利福平的含量为 52+/-6 微克/毫克。在磷酸盐缓冲液中的释放研究表明,在 4.5 天内有 40%的利福平呈线性释放。经冷冻干燥后的微球的 MMAD 为 2.63 微米,适合通过气管内滴注进行气溶胶给药和递送至大鼠肺部。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验